Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases. Hepatology. 2018;68:723–50.

Article  PubMed  Google Scholar 

Kudo M, Kawamura Y, Hasegawa K, et al. Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update. Liver Cancer. 2021;10:181–223.

Article  CAS  PubMed  PubMed Central  Google Scholar 

European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Clinical Practice Guidelines. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018; 69:182–236.

Kono Y, Lyshchik A, Cosgrove D, et al. Contrast enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS®): The official version by the American college of radiology (ACR). Ultraschall Med. 2017;38:85–6.

Article  PubMed  Google Scholar 

Yanagisawa K, Moriyasu F, Miyahara T, et al. Phagocytosis of ultrasound contrast agent microbubbles by kupffer cells. Ultrasound Med Biol. 2007;33:318–25.

Article  PubMed  Google Scholar 

Watanabe R, Matsumura M, Chen CJ, et al. Gray-scale liver enhancement with Sonazoid (NC100100), a novel ultrasound contrast agent; detection of hepatic tumors in a rabbit model. Biol Pharm Bull. 2003;26:1272–7.

Article  CAS  PubMed  Google Scholar 

Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11:317–70.

Article  PubMed  Google Scholar 

Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. Clin Mol Hepatol. 2022;28:583–705.

Article  Google Scholar 

Lee JY, Minami Y, Choi BI, et al. The AFSUMB consensus statements and recommendations for the clinical practice of contrast-enhanced ultrasound using Sonazoid. J Med Ultrasound. 2020;28:59–82.

PubMed  PubMed Central  Google Scholar 

Lv K, Zhai H, Jiang Y, et al. Prospective assessment of diagnostic efficacy and safety of SonazoidTM and SonoVue® ultrasound contrast agents in patients with focal liver lesions. Abdom Radiol. 2021;46:4647–59.

Article  Google Scholar 

Zhai HY, Liang P, Yu J, et al. Comparison of Sonazoid and SonoVue in the diagnosis of focal liver lesions: a preliminary study. J Ultrasound Med. 2019;38:2417–25.

Article  PubMed  Google Scholar 

Virmani J, Kumar V, Kalra N, et al. Neural network ensemble based CAD system for focal liver lesions from B-mode ultrasound. J Digit Imaging. 2014;27:520–37.

Article  PubMed  PubMed Central  Google Scholar 

Hwang YN, Lee JH, Kim GY, et al. Classification of focal liver lesions on ultrasound images by extracting hybrid textural features and using an artificial neural network. Biomed Mater Eng. 2015;26:S1599–611.

PubMed  Google Scholar 

Guo LH, Wang D, Qian YY, et al. A two-stage multi-view learning framework based computer-aided diagnosis of liver tumors with contrast enhanced ultrasound images. Clin Hemorheol Microcirc. 2018;69:343–54.

Article  PubMed  Google Scholar 

Ta CN, Kono Y, Eghtedari M, et al. Focal liver lesions: computer-aided diagnosis by using contrast-enhanced US cine recordings. Radiology. 2018;286:1062–71.

Article  PubMed  Google Scholar 

Li W, Lv XZ, Zheng X, et al. Machine learning-based ultrasomics improves the diagnostic performance in differentiating focal nodular hyperplasia and atypical hepatocellular carcinoma. Front Oncol. 2021;11:544979.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Q, Wei J, Hao X, et al. Improving B-mode ultrasound diagnostic performance for focal liver lesions using deep learning: a multicentre study. eBioMedicine. 2020;56:102777.

Article  PubMed  PubMed Central  Google Scholar 

Zhang H, Guo L, Wang D, et al. Multi-source transfer learning via multi-kernel support vector machine plus for B-mode ultrasound-based computer-aided diagnosis of liver cancers. IEEE J Biomed Health Inform. 2021;25:3874–85.

Article  PubMed  Google Scholar 

Nishida N, Yamakawa M, Shiina T, et al. Artificial intelligence (AI) models for the ultrasonic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts. J Gastroenterol. 2022;57:309–21.

Article  PubMed  PubMed Central  Google Scholar 

Hu HT, Wang W, Chen LD, et al. Artificial intelligence assists identifying malignant versus benign liver lesions using contrast-enhanced ultrasound. J Gastroenterol Hepatol. 2021;36:2875–83.

Article  PubMed  PubMed Central  Google Scholar 

Terminology and Diagnostic Criteria Committee; Japan Society of Ultrasonics in Medicine. Ultrasound diagnostic criteria for hepatic tumors. J Med Ultrason. 2014;41:113–23.

Article  Google Scholar 

Liu D, Liu F, Xie X, et al. Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound. Eur Radiol. 2020;30:2365–76.

Article  PubMed  Google Scholar 

Yasaka K, Akai H, Abe O, et al. Deep learning with convolutional neural network for differentiation of liver masses at dynamic contrastenhanced CT: a preliminary study. Radiology. 2018;286:887–96.

Article  PubMed  Google Scholar 

Hamm CA, Wang CJ, Savic LJ, et al. Deep learning for liver tumor diagnosis part I: development of a convolutional neural network classifier for multi-phasic MRI. Eur Radiol. 2019;29:3338–47.

Article  PubMed  PubMed Central  Google Scholar 

Wu Y, White GM, Cornelius T, et al. Deep learning LI-RADS grading system based on contrast enhanced multiphase MRI for differentiation between LR-3 and LR-4/LR-5 liver tumors. Ann Transl Med. 2020;8:701–11.

Article  PubMed  PubMed Central  Google Scholar 

Takahashi H, Sugimoto K, Kamiyama N, et al. Noninvasive diagnosis of hepatocellular carcinoma on sonazoid-enhanced US: value of the Kupffer phase. Diagnostics. 2022;12:141.

Article  CAS  PubMed  PubMed Central  Google Scholar